HS Genetics Point Toward the Hair Growth Cycle
A missense variant in WNT10A detected by a recent genome-wide association study (GWAS) in hidradenitis suppurativa (HS) suggested…
FDA denies Barth syndrome drug approval, suggests accelerated pathway
For the past decade, Stealth BioTherapeutics has ridden a rollercoaster trying to convince the Food and Drug Administration…
FDA clears Ensoma’s application for rare genetic disorder treatment
CGD patients often suffer from severe, recurrent bacterial and fungal infections. Credit: sergey kolesnikov / Shutterstock. The US…
Amid FDA chaos, approval of a rare disease drug gets delayed — again
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly…
M42 and Juvenescence collaborate on AI-enabled longevity drugs
Abu Dhabi biotech collaboration aims to fast-track clinical-stage therapies that target the root mechanisms of aging and age-related…
D-Wave Quantum and Japanese pharma use quantum computing in drug discovery process
D-Wave Quantum Inc. (NYSE: QBTS) and the pharmaceutical division of Japan Tobacco Inc. (JT) finished a joint proof-of-concept…
Quantum Computing and Drug Development
Dear reader, in recent years we have witnessed a rapid rise in quantum computing, a technology that represents…